Acute onset-low back pain and hip pain secondary to metastatic prostate cancer: a case report

Lishchyna, Natalia; Henderson, Shawn
March 2004
Journal of the Canadian Chiropractic Association;Mar2004, Vol. 48 Issue 1, p5
Academic Journal
Prostatic cancer is the second most common cancer among North American men and the second leading cause of cancer deaths. It may be incidental or contribute to the cause of mechanical back pain. With such high mortality associated with metastasis, early detection is essential for appropriate medical management. Chiropractors are often consulted for back pain of mechanical origin and are in a position to detect conditions in which serious organic pathology may contribute to, or mimic benign musculoskeletal back pain. Patient history and clinical examination coupled with imaging may greatly increase the index of suspicion of prostatic involvement. Outlined is a case where imaging and examination confirmed a diagnosis of organic disease in an individual who opted for chiropractic care for his back pain, but for whom immediate medical management was essential.


Related Articles

  • Epidermoid Anal Canal Carcinoma Metastatic to the Skin. Nazzari, Guido; Drago, Francesco; Malatto, Massimo; Crovato, Franco // Journal of Dermatologic Surgery & Oncology;Nov94, Vol. 20 Issue 11, p765 

    BACKGROUND. Cancers of the anal canal are rare, but their frequency is constantly increasing. Only 10-20% of the patients develop a local recurrence and about 20% distant visceral metastases. OBJECTIVE. To report what we believe to be the first case of skin metastases of epidermoid...

  • Case study: management of advanced prostate cancer with soft tissue metastases. Kirby, Roger // Prostate Cancer & Prostatic Diseases;2005, Vol. 8 Issue 3, p290 

    Presents a medical case of a patient with advanced prostate cancer with soft tissue metastases. Medical history of the patient; Risk of metastatic progression to advanced prostate cancer; Guidelines on hormonal therapy for advanced prostate cancer.

  • Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and Metastasis. Wegiel, Barbara; Bjartell, Anders; Tuomela, Johanna; Dizeyi, Nishtman; Tinzl, Martina; Helczynski, Leszek; Nilsson, Elise; Otterbein, Leo E.; Härkönen, Pirkko; Persson, Jenny Liao // JNCI: Journal of the National Cancer Institute;7/16/2008, Vol. 100 Issue 14, p1022 

    Background Cyclin A1 is a cell cycle regulator that has been implicated in the progression of prostate cancer. Its role in invasion and metastasis of this disease has not been characterized. Methods Immunohistochemistry and cDNA microarray analyses were used to assess protein and mRNA expression...

  • Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial. Bill-Axelson, Anna; Holmberg, Lars; Filén, Frej; Ruutu, Mirja; Garmo, Hans; Busch, Christer; Nordling, Stig; Häggman, Michael; Andersson, Swen-Olof; Bratell, Stefan; Spångberg, Anders; Palmgren, Juni; Adami, Hans-Olov; Johansson, Jan-Erik // JNCI: Journal of the National Cancer Institute;8/20/2008, Vol. 100 Issue 16, p1144 

    Background The benefit of radical prostatectomy in patients with early prostate cancer has been assessed in only one randomized trial. In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now...

  • Novel biomarker may predict lymph node metastases in patients with prostate cancer.  // Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p38 

    The article provides information on a study of the preoperative level of plasma endoglin in patients with prostate cancer. According to the study, the preoperative level of plasma endoglin in patients with clinically localized prostate adenocarcinoma may be the greatest predictor of pelvic lymph...

  • Neurologic Complications of Prostate Cancer. Benjamin, Ramsis // American Family Physician;5/1/2002, Vol. 65 Issue 9, p1834 

    Provides information on neurologic complications of prostate cancer. Details on the anatomy of the disease; Symptoms and diagnosis of spinal metastasis; Treatment of brain metastasis.

  • Very-high-risk localized prostate cancer: definition and outcomes. Sundi, D; Wang, V M; Pierorazio, P M; Han, M; Bivalacqua, T J; Ball, M W; Antonarakis, E S; Partin, A W; Schaeffer, E M; Ross, A E // Prostate Cancer & Prostatic Diseases;Mar2014, Vol. 17 Issue 1, p57 

    Background:Outcomes in men with National Comprehensive Cancer Network (NCCN) high-risk prostate cancer (PCa) can vary substantially-some will have excellent cancer-specific survival, whereas others will experience early metastasis even after aggressive local treatments. Current nomograms, which...

  • Brèves de l'AERIO.  // Oncologie;Oct2013, Vol. 15 Issue 10/11, p543 

    No abstract available.

  • The role of bisphosphonates in hormone-refractory prostate cancer. Saad, Fred; Karakiewicz, Pierre; Perrotte, Paul // World Journal of Urology;Jan2005, Vol. 23 Issue 1, p14 

    Men with advanced prostate cancer are at high risk for developing bone metastases, which result in clinically significant skeletal morbidity. Treatments that prevent skeletal complications in these patients could considerably improve their quality of life. Therefore, this paper reviews the role...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics